MomentumOptions.com Mid-Market Update for 11/6/2017

TXMD Surges on Yuvvexy News

1:25pm (EST)

TherapeuticsMD’s management team met with the FDA last Friday, to discuss the resubmission process for the drug, TX-004HR. The drug, also called Yuvvexy, is a possible treatment for dyspareunia, or moderate-to-severe vaginal pain during sexual intercourse.

The company had previously received a complete response letter, which is the FDA’s equivalent of a rejection letter, for Yuvvexy because its application lacked long-term safety data. The resubmission process can be lengthy and expensive, but the stated today that the FDA has agreed to accept Yuvvexy resubmission without the need to run any additional pre-approval studies.

Given the breathe of fresh air, the company plans to move forward with the resubmission process within the coming weeks. If everything goes well, Yuvvexy could be approved within 2-6 months afterward.

TherapeuticsMD reported a net loss for the quarter of $14.7 million, but losses are typically the norm for companies developing drugs until they mature. The good news is the company has over $148 million in cash and no debt.

As far as the market, trading has been somewhat choppy but the bulls are showing continued strength. The Dow is up 18 points to 23,558 while the S&P 500 is gaining 4 points to 2,591. The Nasdaq is higher by 20 points to 6,785 and the Russell 2000 is adding 4 points to 1,499.

I have updated our current trades so let’s go check the tape.

 

Momentum Options Play List

Closed Momentum Options Trades for 2017: 50-20 (71%). All trades are dated and time stamped for verification. New subscribers can look at the past history to see how the trades have played out or to research our Track Records.

Do not risk more than 5% of your trading account on any one trade but do try to take all of the trades. Please remember, all “Exit Targets” and “Stop Targets” are targets. You should not have any “Hard Stops” entered to close any trades or “Exit Orders” in your brokerage account unless I list one. I will send out a “Profit Alert” or “New Trade” if I want you to close a position or if a new trade comes out. Otherwise, follow instructions at all times in the ‪8am‬ and ‪12pm–2pm (EST)‬ updates. Also, I will usually give you a heads-up if I think I’m going to send a Trade Alert outside of these time frames.

 

TiVo (TIVO, $17.48, up $0.18)

January 20 calls (TIVO180119C00020000, $0.30, flat)

Entry Price: $0.60 (10/31/2017)
Exit Target: $1.20
Return: -50%
Stop Target: None

Action: Resistance is at $17.50-$17.75. Support is at $17.25-$17.

 

Ford (F, $12.33, down $0.03)

November 12 calls (F171117C00012000, $0.40, flat)

Entry Price: $0.45 (10/11/2017)
Exit Target: $0.90
Return: -11%
Stop Target: None

Action: Support is at $12.20-$12.10. Resistance at $12.40-$12.50.

 

Limelight Networks (LLNW, $5.15, down $0.05)

LLNW ‪December 4‬ calls (LLNW171215C00004000, $1.25, down $0.05)

Entry Price: $0.37 (9/21/2017)
Exit Target: $2.00 (Limit Order on half at $2)
Return: 245%
Stop Target: $1 (Stop Limit)

Action: Support is at $5.15-$5.10. Resistance is $5.25-$5.30.

 

TherapeuticsMD (TXMD, $6.11, up $1.75)

TXMD December 7.50 calls (TXMD171215C00007500, $0.25, up $0.05)

Entry Price: $0.95 (8/17/2017)
Exit Target: $1.90
Return: -73%
Stop Target: None

Action: Fresh resistance is at $6.25-$6.50. New support is at $5.75-$5.50 if $6 fails to hold.